Risk
- •
Autoimmune disorders (SLE, RA, scleroderma, cold agglutinin disease).
- •
Lymphoproliferative disorders (CLL, NHL).
- •
Prosthetic heart valves (ball-and-cage, and bileaflet valves). Usually subclinical, but can be severe in up to 15% of pts.
- •
Family history of hemoglobinopathies or RBC membrane defects (thalassemia, sickle cell disease, G6PD deficiency, spherocytosis).
- •
Exposure to drugs (cephalosporins, penicillins, NSAIDs) or other chemicals (naphthalene, fava beans).
- •
Infection ( Clostridium perfringens , Haemophilus influenza type B, malaria, HIV).
- •
Wilson disease (due to toxic effect of copper ions in circulation).
Perioperative Risks
- •
Anemia, hypoxia.
- •
Underlying CV compromise.
- •
Splenomegaly in pts with extravascular hemolysis (within the reticuloendothelial system). Splenectomy is a common surgical procedure in pts with sickle cell disease due to hemolysis and sickling.
- •
Renal failure due to massive hemolysis (e.g., cold agglutinin hemolysis, sickling, drug reaction)
- •
Varying levels of liver disease depending on type of hemolytic anemia. Synthetic function of liver is usually normal, but in severe cases can be compromised.
Perioperative Risks
- •
Anemia, hypoxia.
- •
Underlying CV compromise.
- •
Splenomegaly in pts with extravascular hemolysis (within the reticuloendothelial system). Splenectomy is a common surgical procedure in pts with sickle cell disease due to hemolysis and sickling.
- •
Renal failure due to massive hemolysis (e.g., cold agglutinin hemolysis, sickling, drug reaction)
- •
Varying levels of liver disease depending on type of hemolytic anemia. Synthetic function of liver is usually normal, but in severe cases can be compromised.
Overview
- •
Pts with hemolytic anemia may present with any of the following: fatigue, angina, SOB, tachypnea, tachycardia, or jaundice. The hemolysis can lead to changes in blood viscosity, gallstone production, splenomegaly, and renal failure in severe cases. Many pts will be both iron and folate deficient.
- •
Epidemiology varies by pt population. For example, G6PD is an X-linked condition and its prevalence is near 50% in Kurdish Jews, but around 1:1000 in North American and European populations.
- •
Other things to consider incl monitoring periodic Hct levels, and administering prophylactic antibiotics/vaccinations to pts who have had a splenectomy.